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متالزمة اعتالل مؤخرة الدماغ العكسي يف اثنني من األطفال العمانيني الذين 
يعانون من أمراض الكلى الكامنة
حممد عاطف النجاري، دانا النبهاين، ابت�سام النور، عالء املنزلوي، اأن�س الوجود عبد املغيث
abstract: Posterior reversible encephalopathy syndrome (PRES) is a neurological condition with a combination 
of clinical and radiological features. Clinical symptoms include headaches, confusion, seizures, disturbed vision 
or an altered level of consciousness. Classic magnetic resonance imaging (MRI) findings indicate subcortical and 
cortical oedema, affecting mainly the posterior cerebral region. We report two paediatric cases of PRES with 
underlying renal diseases presenting at the Sultan Qaboos University Hospital in Muscat, Oman, in April 2010 and 
August 2011. The first case was an 11-year-old girl diagnosed with systemic lupus erythematosus and the second was 
a six-and-a-half-year-old boy on peritoneal dialysis due to multi-drug-resistant nephrotic syndrome. Both patients 
were hypertensive and treated with blood pressure control medications. No residual neurological dysfunction was 
noted in the patients at a one-year follow-up and at discharge, respectively. The role of hypertension in paediatric 
PRES cases, among other important risk factors, is emphasised. Additionally, MRI is an important diagnostic 
and prognostic tool. Prompt diagnosis and aggressive management is fundamental to preventing permanent 
neurological damage.
Keywords: Posterior Reversible Encephalopathy Syndrome; Pediatrics; Peritoneal Dialysis; Systemic Lupus Erythe-
matosus; Magnetic Resonance Imaging; Case Report; Oman.
امللخ�ص: متالزمة اعتالل موؤخرة الدماغ العك�سي )PRES( هي حالة ع�سبية مع مزيج من العالمات ال�رسيرية و عالمات �سور الأشعة السينية. 
ت�سمل الأعرا�س ال�رسيرية ال�سداع، الرتباك، الت�سنجات، ا�سطراب الروؤية اأو تغري م�ستوى الوعي. ت�سري النتائج النموذجية للت�سوير بالرنني 
املغناطي�سي )MRI( اإىل ا�ست�سقاء حتت الق�رسية املخية و يف الق�رسية، والتي توؤثر ب�سكل رئي�سي على منطقة الدماغ اخللفية.  هذا  تقرير عن 
حالتني ملتالزمة اعتالل موؤخرة الدماغ العك�سي يف الأطفال الذين يعانون من اأمرا�س الكلى الكامنة يف م�ست�سفى جامعة ال�سلطان قابو�س 
يف م�سقط، عمان، يف اأكتوبر 2010 و اأغ�سط�س 2011. احلالة الأوىل لفتاة تبلغ من العمر اأحد ع�رس عاما �سخ�ست مبر�س الذئبة احلمراء والثانية 
ل�سبي يبلغ من العمر �ستة اأعوام ون�سف على غ�سيل الكلى الربيتوين نتيجة متالزمة كلوية متعددة املقاومة لالأدوية. عانت كال احلالتني من 
ارتفاع �سغط الدم ومت عالجهم باأدوية لل�سيطرة على �سغط الدم. مل يالحظ وجود اأي خلل وظيفي يف اجلهاز الع�سبي لدى املري�سني عند 
خروجهم من امل�ست�سفى و ملدة عام من املتابعة. ي�سري هذا التقرير إىل دور ارتفاع �سغط الدم بني عوامل اخلطورة الهامة الأخرى يف حدوث 
حالت متالزمة اعتالل موؤخرة الدماغ العك�سي يف الأطفال. بالإ�سافة اإىل ذلك، فإنه يجب التاأكيد علي اأهمية الت�سوير بالرنني املغناطي�سي 
كاأداة ت�سخي�سية واإنذارية هامة. الت�سخي�س ال�رسيع والعالج الفاعل هما اأمران اأ�سا�سيان  لوقاية من الأ�رسار الع�سبية الدائم يف هذه املتالزمة. 
مفتاح الكلمات: متالزمة اعتالل موؤخرة الدماغ العك�سي؛ الأطفال؛ غ�سيل الكلى الربيتوين؛ الذئبة احلمراء؛ الت�سوير بالرنني املغناطي�سي؛ تقريرحالة؛ عمان.
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online case report
The following two cases are, to the best of the 
authors’ knowledge, the first reported cases of 
paediatric PRES with underlying renal diseases in 
the Omani population. The aim of this report was to 
increase awareness among physicians and emphasise 
early recognition of this condition in order to improve 
management and outcomes. Common renal risk 
factors that may cause PRES are also elucidated, as 
well as the important role of MRI as a diagnostic and 
prognostic tool.
Posterior reversible encephalopathy syndrome (PRES) is a neurological condition that combines a number of clinical and 
radiological features. Clinical symptoms include 
headaches, confusion, seizures, disturbed vision and 
an altered level of consciousness.1 The classic magnetic 
resonance imaging (MRI) findings are subcortical 
and cortical oedema, mainly affecting the posterior 
cerebral region.2 
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Case 1
An 11-year-old girl with systemic lupus erythematosus 
(SLE) presented to the Sultan Qaboos University 
Hospital (SQUH) in Muscat, Oman, in October 2009. 
The immunological diagnosis of SLE was confirmed 
by positive tests for antinuclear, anti-double-stranded 
DNA, anti-histone and anti-Smith antibodies. Pathology 
assessment of a renal biopsy indicated class IV diffuse 
lupus nephritis with a focal crescent formation. 
The course of the first six months of the illness 
was severe. Initially, she responded to mycophenolate 
mofetil, oral prednisolone and hydroxychloroquine. 
However, the patient had severe hypertension 
which was difficult to control. This was eventually 
regulated with four antihypertensive medications 
(lisionpril, frusemide, hydralazine and amlodipine). 
The hypertension was monitored at the patient’s local 
health centre and peripheral hospital.
At a follow-up visit in April 2010, the patient’s blood 
pressure (BP) was high at 180/100 mmHg (normal 
age- and gender-matched range: 95th percentile, 
119/78 mmHg; 99th percentile, 126/86 mmHg). During 
the follow-up visit, the patient suddenly developed 
severe headaches while showing signs of agitation and 
abnormal behaviour. In addition, she began having 
generalised tonic-clonic seizures. A central nervous 
system examination revealed an impaired attention 
span, good coordination and normal cranial nerve 
activity. No meningeal or cerebellar signs and no focal 
neurological deficit were observed. However, there 
was a marked weakness in the proximal muscle group, 
which was associated with normal tone and increased 
reflexes in the lower limbs. An eye examination 
showed equal pupils reactive to light, while a fundus 
examination showed small retinal and conjunctival 
haemorrhages with no signs of papilloedema. Other 
clinical systemic examinations were normal. The child 
was admitted to the SQUH Paediatric Intensive Care 
Unit (PICU) for respiratory support, due to recurrent 
seizures that led to altered sensorium. In addition, she 
had very high BP readings (200/130 mmHg) [Table 1].
The differential diagnosis for the patient included 
hypertensive encephalopathy, intracranial bleeding, 
a cerebrovascular stroke and cerebral vasculitis. 
On admission to the PICU, urgent brain scans were 
performed in order to correlate the patient’s clinical 
deterioration and neurological manifestations. Initial 
MRI brain examinations revealed hyperintense areas 
in the bilateral cortical and subcortical white matter, 
observed at the frontal-parietal and parietal-occipital 
junctions. Mild cortical involvement was also noted 
[Figure 1]. Diffusion images and apparent diffusion 
coefficient mapping displayed no evidence of diffusion 
restriction. The radiological findings indicated a 
diagnosis of PRES. 
Electroencephalography showed bilateral slow 
wave activity and no epileptic discharges. The 
laboratory investigations indicated anaemia with a 
haemoglobin level of 10 g/dL, a normal coagulation 
profile and the following other blood levels: sodium 
of 138 mmol/L (normal range: 135–145 mmol/L); 
potassium of 3.5 mmol/L (normal range: 2.5–5.1 
mmol/L); creatinine of 45 μmol/L (normal range: 
15–31 μmol/L); urea of 6.5 mmol/L (normal range: 
2.1–7.1 mmol/L); calcium of 2.45 mmol/L (normal 
range: 2.15–2.55 mmol/L); and serum magnesium of 
0.9 mmol/L (normal range 0.7–0.95 mmol/L). 
Methylprednisolone and low-dose cyclophos-
phamide were prescribed for the control of SLE 
 
Figure 1A & B: Axial fluid-attenuated inversion recovery 
magnetic resonance images of an 11-year-old girl diagnosed 
with systemic lupus erythematosus showing bilateral 
cortical and subcortical white matter. Hyperintense areas 
can be seen in the frontal, posterior temporal, parietal 
and occipital regions (arrows). Based on clinical and 
radiological findings, a diagnosis of posterior reversible 
encephalopathy syndrome was made. 
Table 1: Summary of the clinical characteristics and risk 
factors for the two presented patients with posterior 
reverse encephalopathy syndrome




Diagnosis SLE with 
multisystem 
involvement










SBP in mmHg 200 180
DBP in mmHg 130 120





SLE = systemic lupus erythematous; ERSD = end-stage renal disease; 
CAPD = continuous ambulatory peritoneal dialysis; SBP = systolic 
blood pressure; DBP = diastolic blood pressure.
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In August 2011, the child was transferred with 
assisted mechanical ventilation to the Department of 
Child Health at SQUH. On initial clinical assessment, 
the patient showed signs of dehydration with fair 
peripheral perfusion and warm extremities. His apex 
beat was forceful with normal heart sounds, a grade 
two ejection systolic murmur at the base of the heart 
and no gallop rhythm. There were no signs suggestive 
of cardiac failure and no evidence of pericardial 
effusion. The chest was clear with no crepitation. The 
central nervous system exam showed no neurological 
deficits and normal bilateral deep tendon reflexes. 
A fundus examination showed grade one hyper- 
tensive retinopathy. 
Laboratory investigations revealed anaemia with 
a haemoglobin level of 7 g/dL, a normal coagulation 
profile, normal inflammatory markers and the 
following other blood levels: sodium of 123 mmol/L 
(normal range: 135–145 mmol/L); potassium of 
3.2 mmol/L (normal range: 2.5–5.1 mmol/L); creatinine 
of 586 μmol/L (normal range: 15–31 μmol/L); urea of 
15.8 mmol/L (normal range: 2.1–7.1 mmol/L); calcium 
of 2.3 mmol/L (normal range: 2.15–2.55 mmol/L); 
and serum magnesium of 0.8 mmol/L (normal range: 
0.7–0.95 mmol/L). 
Echocardiography showed left ventricular hyper-
trophy with trivial aortic regurgitation and no peri-
cardial effusion. An initial computed tomography 
scan showed bilateral hypodense areas at the 
occipital regions with a vasogenic oedema pattern 
distribution [Figure 2]. MRI brain images showed 
typical subcortical white matter areas of oedema at the 
frontal-parietal-temporal-occipital regions [Figure 3]. 
Based on the clinical and radiological findings, PRES 
was suspected. 
Management of the patient’s high BP required a 
labetalol infusion. After controlling the hypertension, 
activity and labetalol and hydralazine infusions 
were administered for BP control. The patient was 
weaned from the ventilator after the hypertension 
had been controlled and she was shifted gradually to 
oral antihypertensive medications. A follow-up MRI 
showed a significant improvement, with residual 
abnormally hyperintense areas at the superior frontal 
and left parietal regions. Clinical and radiological 
assessments after one year showed no residual 
neurological dysfunction.
Case 2
A six-and-a-half-year-old boy presented to SQUH in 
Muscat, Oman, in August 2011 with end-stage renal 
disease secondary to multi-drug-resistant nephrotic 
syndrome. The diagnosis of nephrotic syndrome 
had been established at the age of 14 months 
when the patient presented to a regional hospital 
in Oman with proteinuria, haematuria and hyper- 
tension. He showed no response to pulse methyl-
prednisolone, cyclophosphamide or mycophenolate 
mofetil. The patient started continuous ambulatory 
peritoneal dialysis at the age of six years due to a 
progressive deterioration of renal function, fluid 
overload and hypertension. He continued on dialysis for 
six months with other renal replacement medications, 
including vitamin D and darbepoetin alfa. 
The child presented to SQUH with hypertension, 
generalised oedema, depressed sensorium and 
generalised tonic-clonic convulsions. BP readings 
were very high, reaching 180/120 mmHg. While in 
a state of disturbed consciousness, he was intubated 
and ventilated in order to secure his respiratory 
airway. The differential diagnosis was hypertensive or 
uremic encephalopathy, intracranial bleeding and a 
cerebrovascular stroke. 
 
Figure 2A & B: Axial non-enhanced computed 
tomography images of a six-and-a-half-year-old boy 
on peritoneal dialysis due to multi-drug-resistant 
nephrotic syndrome and with suspected posterior 
reversible encephalopathy syndrome. Bilateral subcortical 
hypodense areas were observed in the occipital and 
posterior parietal regions (arrows). Similar areas can be 
seen to a lesser extent in the frontal regions (arrowheads). 
 
Figure 3A & B: Axial magnetic resonance fluid 
attenuation inversion recovery images of a six-and-a-
half-year-old boy on peritoneal dialysis due to multi-
drug-resistant nephrotic syndrome showing bilateral 
subcortical hyperintense areas, mainly at the frontal-
occipital-parietal regions (arrows). Similar areas are also 
seen at the right posterior temporal region (arrowhead). 
Based on clinical and radiological findings, a diagnosis of 
posterior reversible encephalopathy syndrome was made.
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the patient was successfully weaned off the ventilator 
and was started on oral antihypertensive medications. 
A neurological examination at the time of discharge 
was normal. 
Both of the patients’ guardians gave consent to 
use the patients’ medical information and images for 
scientific purposes. 
Discussion
PRES is a neurological syndrome with a combination 
of clinical and radiological features. Clinical 
presentations include seizures, headaches, visual 
disturbance and focal neurological signs.1 Headaches 
are the main clinical presentation followed by 
confusion and drowsiness. Focal neurological 
deficit is an uncommon association with PRES.2 
The typical radiological findings are subcortical and 
cortical oedema in the posterior cerebral regions. 
Hypertension is the main triggering factor for PRES 
while other risk factors that predispose to hypertension 
can also be present.2 
PRES is a reversible condition if it is managed 
early and appropriately, but can otherwise be 
fatal.1,2 The underlying mechanism that triggers this 
disease is not well understood and two conflicting 
theories exist regarding its pathogenesis. Both 
postulated mechanisms are based on the central 
role of hypertension. The first theory suggests 
that hypertension could cause a breakdown of the 
autoregulatory system in cerebral circulation, leading 
to brain oedema. According to the second theory, 
hypertension causes activation of the autoregulatory 
system, which results in vasoconstriction of the brain 
vessels with hypoperfusion, ischaemia and subsequent 
fluid leakage.3,4 However, a large number of patients 
with PRES do not have hypertension.3,4 Consequently, 
Marra et al. recently described the endothelial 
hypothesis; this theory differs from those earlier as 
it asserts that hypertension does not necessarily have 
to be present for PRES to develop.4 The hypothesis 
suggests that an immune-related cascade can cause 
PRES through the weakening of brain vessels, leading 
to fluid leakage and oedema.4 
PRES has been extensively described in both 
adults and children. The most common risk factor 
is a hypertensive crisis.5 Therefore, any condition 
that predisposes to hypertension can lead to the 
development of PRES. This includes many renal 
conditions affecting the glomerulus, such as lupus 
nephritis;6,7 the renal vessels, such as renal artery 
stenosis;8 and those conditions with renal anatomical 
defects such as grade four vesicoureteral reflux.9 
In addition, many medications like steroids and 
cyclosporine can raise BP and therefore increase the 
risk of PRES.10,11 Patients on dialysis can also develop 
PRES if they become hypertensive.12,13 Seizures are 
a common and frequently encountered symptom 
of PRES, among a wide range of other neuro- 
logical symptoms.5
In the first case presented in the current report, 
the patient had multiple risk factors that contributed 
to the onset of PRES. These included lupus nephritis 
confirmed by renal biopsy, the use of methylprednisone 
for disease control and extremely high BP. The 
patient also presented with headaches, drowsiness 
and seizures, which are the most common clinical 
signs of PRES.1 The second case emphasised the role 
of hypertension in patients on peritoneal dialysis. 
However, darbepoetin alfa may also be a contributing 
factor to the development of PRES, as it may have 
contributed to the raised BP. Both of the cases were 
managed promptly and appropriately, which led to 
favourable outcomes for both patients. 
MRI can be used as a diagnostic and prognostic 
tool for PRES. The classic MRI feature in PRES cases 
is subcortical oedema in the parietal-occipital region.14 
However, in recent years, more atypical findings of 
PRES have been described. Kastrup et al. reported 
that the frontal region was the area most commonly 
affected in a study of PRES cases.15 The MRI brain 
scans of the two patients in the current report confirm 
this, as the frontal region was involved in both 
cases. Reversibility of MRI findings is suggestive of 
a good prognosis.16 Thus, leukoencephalopathy with 
severe hypertension is reversible both clinically and 
radiologically in the majority of children after the 
control of hypertension.17 However, the literature has 
shown that a few patients may have residual damage 
and need to be followed-up.17
The present report highlights the role of risk 
factors such as hypertension in the development of 
PRES in two paediatric renal cases. Strict monitoring is 
mandatory for such critical patients, including the use 
of BP measurement devices with appropriate paediatric 
cuffs for the child’s age. It is important to recognise 
such cases early to allow for prompt treatment and 
potential reversal of the syndrome. The two cases 
presented here demonstrated that regions other than 
the posterior brain can be affected in PRES and that 
MRI is a useful diagnostic tool. More MRI devices 
are needed in hospitals throughout Oman, as well 
as more training for physicians in diagnosing typical 
and atypical forms of PRES. Finally, prompt diagnosis 
and aggressive management is the cornerstone for 
the prevention of permanent neurological damage in 
PRES patients.
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Conclusion
Hypertension is known to be one of the most import-
ant risk factors leading to PRES but is uncommon 
among patients with renal diseases. To the best of the 
authors’ knowledge, these two paediatric PRES cases 
with underlying renal diseases are the first reported 
among the Omani population. The findings from 
these two cases suggest that an increased awareness 
of effective BP monitoring in peripheral hospitals in 
Oman is necessary. MRI scanning is also recommended 
as a valuable diagnostic and prognostic tool. PRES 
is under-recognised and requires multidisciplinary 
care because of its potentially severe consequences. 
Prompt diagnosis and treatment of risk factors are 
critical in helping to prevent permanent neurological 
damage among these patients.
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